Supplementary Figure 4: CXCL8 promoted the migration and invasion of TE-9 cells. (A) (i) For the transwell migration
assay, TE-9 cells were plated on the transwell in serum-free RPMI-1640 at 5.0 × 10 5 cells/well. rhCXCL8 was added in the upper chamber at 10 ng/ml. The cell inserts were set on 24-well plates in RPMI-1640 with 1% FBS for 24 h. The migrated cells on the underside of the membrane were stained by Diff-Quik and counted. The results are mean ± SEM. (ii) For the transwell invasion assay, TE-9 cells were seeded on a transwell coated with matrigel in serum-free RPMI-1640 at 5.0 × 10 5 cells/well. rhCXCL8 was added in the transwell at 100 ng/ml. The cell inserts were set on 24-well plates in RPMI-1640 with 1% FBS for 48 h. The invaded cells on the underside of the membrane were stained by Diff-Quik and counted. (B) (i) TE-9 cells were plated on the upper chamber with rhCXCL8 at 10 ng/ml combined with the inhibitor against PI3K (LY294002, 10 μM) or MEK1/2 (PD98059, 10 μM). DMSO (0.2μl/ml) was added as negative control. After 24 h, the migrated cells were counted. (ii) TE-9 cells were plated on the upper transwell coated with matrigel. rhCXCL8 was added in the transwell combined with LY294002 (10 μM) or PD98059 (10 μM). DMSO (0.2μl/ml) was added to negative control. After 48 h, the invaded cells were counted. (C) (i) CXCR1-or CXCR2-silenced TE-9 cells were plated on the upper transwell with rhCXCL8 at 10 ng/ml. After 24 h, the migrated cells were counted. (ii) CXCR1-or CXCR2-silenced TE-9 cells were plated on the upper transwell coated with matrigel. rhCXCL8 was added to the transwell at 100 ng/ml. After 48 h, the invaded cells were counted. (D) (i) TE-9 cells were plated on the upper transwell with rhCXCL8 at 10 ng/ml combined with the neutralizing antibody against CXCR1 (0.2 μg/ml) or CXCR2 (1.0 μg/ml). Mouse IgG (1.0 μg/ml) was added to negative control. The concentrations of neutralizing antibodies were based on the manufacturer's instructions. (ii) TE-9 cells were plated on the upper transwell coated with matrigel. rhXCL8 was added to the upper transwell at 100 ng/ml combined with the neutralizing antibody against CXCR1 (0.2 μg/ml) or CXCR2 (1.0 μg/ml). Mouse IgG (1.0 μg/ml) was added to negative control. After 48 h, the invaded cells were counted. NS, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
